Increased secretion of basement membrane-degrading metalloproteinases in pig saphenous vein into carotid artery interposition grafts.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  1999-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.ATV.19.7.1640PMID 10397681
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer

  2004cited by this paper
• External stenting reduces long-term medial and neointimal thickening and platelet derived growth factor expression in a pig model of arteriovenous bypass grafting

  1998cited by this paper
• Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis.

  1998cited by this paper
• Adenovirus-Mediated Gene Transfer of the Human TIMP-1 Gene Inhibits Smooth Muscle Cell Migration and Neointimal Formation in Human Saphenous Vein

  1998cited by this paper
• Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer.

  1998cited by this paper
• Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers.

  1998cited by this paper
• Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.

  1998cited by this paper
• Surgical preparative injury and neointima formation increase MMP-9 expression and MMP-2 activation in human saphenous vein.

  1997cited by this paper
• Matrix Metalloproteinase Inhibitor Drugs

  1997cited by this paper
• Increased secretion of gelatinases A and B from the aortas of cholesterol fed rabbits: relationship to lesion severity.

  1997cited by this paper
• Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells.

  1996cited by this paper
• Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer.

  1996cited by this paper
• An essential role for platelet-derived growth factor in neointima formation in human saphenous vein in vitro.

  1996cited by this paper
• Upregulation of basement membrane-degrading metalloproteinase secretion after balloon injury of pig carotid arteries.

  1996cited by this paper
• Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo.

  1996cited by this paper
• Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury.

  1996cited by this paper
• Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor.

  1996cited by this paper
• The recombinant catalytic domain of membrane‐type matrix metalloproteinase‐1 (MT1‐MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP‐2

  1996cited by this paper
• Influence of external stent size on early medial and neointimal thickening in a pig model of saphenous vein bypass grafting.

  1996cited by this paper
• Arterial conduits in myocardial revascularisation

  1995cited by this paper
• Marked acceleration of the metastatic phenotype of a rat bladder carcinoma cell line by the expression of human gelatinase a

  1995cited by this paper
• Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase

  1995cited by this paper
• Neointimal fibrosis in vascular pathologies: role of growth factors and metalloproteinases in vascular smooth muscle proliferation.

  1995cited by this paper
• Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion.

  1994cited by this paper
• Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat.

  1994cited by this paper
• A matrix metalloproteinase expressed on the surface of invasive tumour cells

  1994cited by this paper
• Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation.

  1994cited by this paper
• Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

  1994cited by this paper
• Release of platelet-derived growth factor activity from pig venous arterial grafts.

  1994cited by this paper
• Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery.

  1994cited by this paper
• Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury.

  1993cited by this paper
• Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis.

  1993cited by this paper
• Proposed roles for growth factors in mediating smooth muscle proliferation in vascular pathologies.

  1993cited by this paper
• Surgical preparation induces injury and promotes smooth muscle cell proliferation in a culture of human saphenous vein.

  1993cited by this paper
• Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation.

  1992cited by this paper
• Time-course of medial and intimal thickening in pig venous arterial grafts: relationship to endothelial injury and cholesterol accumulation.

  1992cited by this paper
• Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries.

  1991cited by this paper
• Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF

  1991cited by this paper
• Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells.

  1991cited by this paper
• Distention promotes platelet and leukocyte adhesion and reduces short-term patency in pig arteriovenous bypass grafts.

  1990cited by this paper
• PDGF ligand and receptor gene expression during repair of arterial injury

  1990cited by this paper
• Metalloproteinases and their inhibitors in matrix remodeling.

  1990cited by this paper
• The future of saphenous vein as a coronary artery bypass conduit.

  1989cited by this paper
• Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissues

  1989cited by this paper
• Blood cells and arteries in hypertension and atherosclerosis

  1989cited by this paper
• Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells

  1988cited by this paper
• Lectins as markers of endothelial cells: comparative study between human and animal cells

  1988cited by this paper
• Replication of Smooth-Muscle Cells in Atherosclerosis

  1988cited by this paper
• Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions.

  1986cited by this paper

• Assessment of atherosclerosis in ischemic stroke by means of ultrasound of extracranial/intracranial circulation and serum, urine, and tissue biomarkers.

  2022cites this paper
• A Review on the Relationship between Matrix Metalloproteinases (Mmps) and their Natural Inhibitors (Tissue Inhibitors Of Matrix Metalloproteinases [Timps]) and the Success of an Autologous Arteriovenous Fistula (Avf)

  2021cites this paper
• Current understanding of intimal hyperplasia and effect of compliance in synthetic small diameter vascular grafts.

  2020cites this paper
• External stents inhibit intimal hyperplasia of rabbit autologous vein grafts via modulation of matrix metalloproteinase-2 expression

  2019cites this paper
• Arteriovenous conduits for hemodialysis: how to better modulate the pathophysiological vascular response to optimize vascular access durability.

  2019cites this paper
• Vascular related pathologies in cardiovascular disease and cancer

  2018cites this paper
• Dynamic Macrophages: Understanding Mechanisms of Activation as Guide to Therapy for Atherosclerotic Vascular Disease

  2018cites this paper
• Matrix Gelatinases in Atherosclerosis and Diabetic Nephropathy: Progress and Challenges.

  2017cites this paper
• Evidence for the Involvement of Matrix-Degrading Metalloproteinases (MMPs) in Atherosclerosis.

  2017cites this paper
• Chebulinic acid inhibits smooth muscle cell migration by suppressing PDGF-Rβ phosphorylation and inhibiting matrix metalloproteinase-2 expression

  2017cites this paper
• Stabilising suppressor of cytokine signalling 3 (SOCS3) protein levels to limit neointimal hyperplasia

  2016cites this paper
• Development and evaluation of in vivo tissue engineered blood vessels in a porcine model.

  2016cites this paper
• Salvianolic acid A inhibits endothelial dysfunction and vascular remodeling in spontaneously hypertensive rats.

  2016cites this paper
• Future research directions to improve fistula maturation and reduce access failure.

  2016cites this paper
• Vein graft disease in a knockout mouse model of hyperhomocysteinaemia

  2016cites this paper
• Mechanism For Eph-B4 Regulation Of Vein Graft Adaptation

  2014cites this paper
• Vein graft adaptation and fistula maturation in the arterial environment.

  2014cites this paper
• Matrix metalloproteinases in coronary artery disease.

  2014cites this paper
• Intravenous transfusion of endothelial colony-forming cells attenuates vascular degeneration after cerebral aneurysm induction.

  2014cites this paper
• Matrix metalloproteinases, atherosclerosis, proteinuria and kidney disease: Linkage-based approaches.

  2013cites this paper
• Preexisting High Expression of Matrix Metalloproteinase-2 in Tunica Media of Saphenous Vein Conduits Is Associated with Unfavorable Long-Term Outcomes after Coronary Artery Bypass Grafting

  2013cites this paper
• Effects of exercise on markers of venous remodeling in lungs of horses.

  2013cites this paper
• Vein graft failure: current clinical practice and potential for gene therapeutics

  2012cites this paper
• Perivascular administration of drugs and genes as a means of reducing vein graft failure.

  2012cites this paper
• Matrix metalloproteinase inhibition therapy for vascular diseases.

  2012cites this paper
• Matrix Metalloproteinase (MMP)-3 Activates MMP-9 Mediated Vascular Smooth Muscle Cell Migration and Neointima Formation in Mice

  2011cites this paper
• Sustained Reduction of Vein Graft Neointima Formation by Ex Vivo TIMP-3 Gene Therapy

  2011cites this paper
• In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor.

  2010cites this paper
• Role of Lysyl Oxidases in Neointima Development in Vascular Allografts

  2010cites this paper
• Molecular Regulation of Contractile Smooth Muscle Cell Phenotype: Implications for Vascular Tissue Engineering

  2010cites this paper
• A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease.

  2010cites this paper
• Wall Shear Stress Measurement Using Phase Contrast Magnetic Resonance Imaging With Phase Contrast Magnetic Resonance Angiography in Arteriovenous Polytetrafluoroethylene Grafts

  2009cites this paper
• Roles of Matrix Metalloproteinases in Flow-Induced Outward Vascular Remodeling

  2009cites this paper
• Roles of Macrophages in Flow-Induced Outward Vascular Remodeling

  2009cites this paper
• Realistic Temporal Variations of Shear Stress Modulate MMP-2 and MCP-1 Expression in Arteriovenous Vascular Access

  2009cites this paper
• Established neointimal hyperplasia in vein grafts expands via TGF-beta-mediated progressive fibrosis.

  2009cites this paper
• MMP-9 and -12 cause N-cadherin shedding and thereby beta-catenin signalling and vascular smooth muscle cell proliferation.

  2009cites this paper
• Expansive remodeling in venous bypass grafts: novel implications for vein graft disease.

  2008cites this paper
• Cellular Mechanisms of Bypass Vein Graft Arterialization and Approaches to Attenuate Graft Remodeling

  2008cites this paper
• Construction of an adenovirus vector carrying the human tissue inhibitor of metalloproteinase 2 gene.

  2008cites this paper
• Wirkungen der Gerinnungsfaktoren Thrombin und Faktor-Xa auf vaskuläre Zellen des Menschen

  2008cites this paper
• Venous graft remodeling : novel mechanisms and pharmaco-modulation strategies

  2008cites this paper
• Increased Matrix Metalloproteinase 2 Activity in the Human Internal Mammary Artery Is Associated with Ageing, Hypertension, Diabetes and Kidney Dysfunction

  2008cites this paper
• Preclinical Evaluation of New Drug-Eluting Biodegradable Poly-D/L-lactic Acid Vascular Stent

  2008cites this paper
• Accelerated intimal hyperplasia in aortocoronary internal mammary vein grafts in minipigs

  2008cites this paper
• Remodeling of experimental arteriovenous fistula with increased matrix metalloproteinase expression in rats.

  2007cites this paper
• Mechanical forces and human saphenous veins: coronary artery bypass graft implications.

  2007cites this paper
• Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts.

  2007cites this paper
• Smooth muscle cells cultured from human saphenous vein exhibit increased proliferation, invasion, and mitogen-activated protein kinase activation in vitro compared with paired internal mammary artery cells.

  2007cites this paper
• Matrix metalloproteinases in peripheral vascular disease.

  2007cites this paper
• The use of commercially available antibodies in the study of vascular disease using a porcine model

  2007cites this paper
• The Inhibitory Effect of Minocycline on Hypertrophic Scarring

  2007cites this paper
• Pharmacologic inhibition of vein graft neointimal hyperplasia.

  2006cites this paper
• Gene expression changes evoked in a venous segment exposed to arterial flow.

  2006cites this paper
• Matrix metalloproteinase expression in vein grafts: role of inflammatory mediators and extracellular signal-regulated kinases-1 and -2.

  2006cites this paper
• In vivo (animal) models of vein graft disease.

  2006cites this paper
• harmacologic inhibition of vein graft neointimal yperplasia

  2006cites this paper
• Early differential MMP-2 and -9 dynamics during flow-induced arterial and vein graft adaptations.

  2006cites this paper
• Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates.

  2006cites this paper
• Why don't fistulas mature?

  2006cites this paper
• Review In vivo (animal) models of vein graft disease

  2006cites this paper
• In vivo temperature heterogeneity is associated with plaque regions of increased MMP-9 activity.

  2005cites this paper
• Differential Regulation of Hyaluronic Acid Synthase Isoforms in Human Saphenous Vein Smooth Muscle Cells: Possible Implications for Vein Graft Stenosis

  2005cites this paper
• Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture.

  2005cites this paper
• Smooth Muscle Cells : Possible Implications for Vein Graft Stenosis Differential Regulation of Hyaluronic Acid Synthase Isoforms in Human Saphenous Vein

  2005cites this paper
• Pressure distention compared with pharmacologic relaxation in vein grafting upregulates matrix metalloproteinase-2 and -9.

  2005cites this paper
• Adventitial remodeling with increased matrix metalloproteinase-2 activity in a porcine arteriovenous polytetrafluoroethylene grafts.

  2005cites this paper
• Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.

  2004cites this paper
• Overexpression of p53 increases lumen size and blocks neointima formation in porcine interposition vein grafts.

  2004cites this paper
• The pathobiology of aortic aneurysms.

  2004cites this paper
• Matrix metalloproteinase inhibition reduces intimal hyperplasia in a porcine arteriovenous-graft model.

  2004cites this paper
• Tissue inhibitor of metalloproteinases-4 suppresses vascular smooth muscle cell migration and induces cell apoptosis.

  2004cites this paper
• The effect of novel immunosuppressants on extracellular matrix remodelling and the expression of fibrosis associated genes in an experimental model of allograft vasculopathy

  2003cites this paper
• Statins in coronary bypass surgery: rationale and clinical use.

  2003cites this paper
• Can Angiotensin-converting Enzyme Inhibitors Reverse Atherosclerosis?

  2003cites this paper
• Gene therapy for vascular diseases

  2003cites this paper
• Metalloproteinases and plasminogen activators in vessel remodeling

  2003cites this paper
• Rapamycin inhibits vascular remodeling in an experimental model of allograft vasculopathy and attenuates associated changes in fibrosis-associated gene expression.

  2003cites this paper
• Relationship between type IV collagen degradation, metalloproteinase activity and smooth muscle cell migration and proliferation in cultured human saphenous vein.

  2003cites this paper
• Regulation of Matrix Metalloproteinase (Matrixin) Genes in Blood Vessels: A Multi-Step Recruitment Model for Pathological Remodelling

  2003cites this paper
• Targeted Disruption of the Matrix Metalloproteinase-9 Gene Impairs Smooth Muscle Cell Migration and Geometrical Arterial Remodeling

  2002cites this paper
• Metalloproteinase inhibitors: biological actions and therapeutic opportunities

  2002cites this paper
• Microemulsion cyclosporin inhibits vascular remodelling and attenuates associated changes in profibrotic gene expression in an experimental model of allograft vasculopathy

  2002cites this paper
• The role of matrix metalloproteinases in vascular disease

  2002cites this paper
• Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration.

  2002cites this paper
• An investigation into the migration and proliferation of human venous smooth muscle cells in intimal hyperpasia in vein grafts

  2002cites this paper
• Use of angiotensin-converting enzyme inhibitors in patients with diabetes and coronary artery disease.

  2002cites this paper
• Matrix metalloproteinases and tissue inhibitors of metalloproteinases in hamster aortic atherosclerosis: correlation with in-situ zymography.

  2002cites this paper
• Gene Transfer of the Urokinase-Type Plasminogen Activator Receptor-Targeted Matrix Metalloproteinase Inhibitor TIMP-1.ATF Suppresses Neointima Formation More Efficiently Than Tissue Inhibitor of Metalloproteinase-1

  2002cites this paper
• [Structural and functional aspects of the human saphenous vein used as aorto-coronary graft in myocardial revascularization].

  2001cites this paper
• Atherosclerosis: cell biology and lipoproteins.

  2001cites this paper
• Shear force regulates matrix metalloproteinase activity in human saphenous vein organ culture.

  2001cites this paper
• Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3.

  2000cites this paper
• Molecular mechanisms in intimal hyperplasia

  2000cites this paper
• Altered balance between extracellular proteolysis and antiproteolysis is associated with adaptive coronary arteriogenesis.

  2000cites this paper
• All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo.

  2000cites this paper
• This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba

  year unknowncites this paper